Sam Freeze is a genetic counselor with deep expertise in clinical genomics and commercial diagnostic strategy. They have held leadership roles in market access and payer policy, currently serving as Senior Director of Global Diagnostics Pathways and Policy at Eli Lilly and Company since 2025. Previously, Sam directed market access precision medicine at ADVI Health and managed payer policy at GeneDx. They earned a Master of Science in Human/Medical Genetics from the University of Cincinnati and a Bachelor of Science in Biology from Indiana University Bloomington.
This person is not in any teams
This person is not in any offices